ANDA 89370, held by IDT Australia. Procainamide Hydrochloride.
As of Nov 21, 2026, ANDA 89370 (Procainamide Hydrochloride), held by IDT Australia, was first approved by FDA on Jan 9, 1987, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 9, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Procainamide Hydrochloride500MG · tablet, extended release;oral | Procainamide Hydrochloride | Discontinued |
| Jan 7, 1992 | Supplement 9Labeling | Approved | None posted |
| Jan 23, 1989 | Supplement 7Labeling | Approved | None posted |
| Nov 29, 1988 | Supplement 6Labeling | Approved | None posted |
| Jan 9, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters